Baxter International Inc. (BAX) Fair Value 2026

BAX · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.3 /10

32 fundamental signals · 6 models active

Value Trap Risk

WARN (48/100)

Quick Summary — As of 2026-08-28, Baxter International Inc. (BAX) trades at $26.13, versus a $22.95 median fair value across its 6 active models — 12.2% below the current price. QOC: 6.3/10. Value Trap Risk: 48/100 (WARN). 6/13 models active.

Key Facts

Ticker
BAX
Price
$26.13
Quality Score
6.3/10
Value Trap Risk
48/100
Models Active
6/13
Last Updated
Strength: Regime Cross-Sectional suggests +37.9% upside with 50% confidence
Risk: Value Trap score of 48 suggests caution despite apparent undervaluation

Is Baxter International Inc. (BAX) Undervalued or Overvalued in 2026?

According to CirclFi’s 6-model valuation engine, Baxter International Inc. (BAX) appears overvalued as of : the median of 6 independent fair value estimates is $22.95, 12.2% below the current price of $26.13. Estimates range from $4.49 to $36.03. BAX scores 6.3/10 on fundamental quality and 48/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. BAX’s -12.2% gap is narrower than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Baxter International Inc. Stock in 2026? →

What Fair Value Does Each Model Give BAX?

6 Intrinsic Value Models vs. Current Price ($26.13)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $23.79 -9.0%
Intrinsic · High Conviction
 $20.52 -21.5%
Relative · High Conviction
 $36.03 +37.9%
Unlock the Full Matrix

Access 3 additional models including PWERM, Sentiment SOTP, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is BAX's Fair Value Range?

Spread across 6 independent models · $4.49 to $36.03

CirclFi's 6 active models place Baxter International Inc. (BAX) between $4.49 and $36.03 per share, a spread of 137% of the median. The median of that range — $22.95 — is the fair value CirclFi publishes for BAX, against a current price of $26.13.

Low · Sentiment SOTPHigh · Regime Cross
$4.49median $22.95$36.03
Where the range comes from
Most bearish modelSentiment SOTP$4.49
Most bullish modelRegime Cross-Sectional$36.03
Model agreement2 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for BAX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on BAX, not a CirclFi price target. How each model works →

What Is Baxter International Inc. (BAX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Baxter International Inc. at its current price of $26.13. The median intrinsic value is estimated at $22.95 (-12.2% vs price), with 4 models flagging overvaluation risk. The most optimistic model, Regime Cross, places fair value at $36.03 (+37.9%), while Sentiment SOTP — the most conservative — estimates $4.49 (-82.8%). This +120.7% gap reflects genuine analytical uncertainty about Baxter International Inc.'s intrinsic worth.

What Do the Models Say About BAX?

6 of 13 models are currently active for BAX. Of these, 2 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for BAX is $22.95 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does BAX Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, BAX ranks #31 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Baxter International Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is BAX a Value Trap?

CirclFi's Value Trap algorithm assigns BAX a score of 48/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for Baxter International Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Baxter International Inc. is rated at 6.3/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +120.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BAX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BAX's 6 active models, average confidence is 38%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Baxter International Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

KRMDKORU Medical Systems, Inc.QOC 6.5MMEDMiniMed Group, Inc.QOC 6.3AVTRAvantor, Inc.QOC 6.5BLCOBausch + Lomb CorporationQOC 6.3ANGOAngioDynamics, Inc.QOC 6.7TFXTeleflex IncorporatedQOC 6.2LUCYLucyd, IncQOC 5.6LMATLeMaitre Vascular, Inc.QOC 9.3STVNStevanato Group S.p.A.QOC 7.7ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: KRMD · MMED · AVTR · BLCO · ANGO · TFX · LUCY · LMAT · STVN · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to BAX?

7 companies across all industries closest to BAX’s Quality of Company score of 6.3/10.

DOYUDouYu International Holdings LimitedQOC 6.3HCATHealth Catalyst, Inc.QOC 6.3SEPNSepterna, Inc.QOC 6.3PODCPodcastOne, Inc.QOC 6.3WHLRWheeler Real Estate Investment Trust, Inc.QOC 6.3MGTEMarblegate Capital CorporationQOC 6.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DOYU · HCAT · SEPN · PODC · WHLR · MGTE · NVDA

Where Does BAX Sit in CirclFi's Medical Instruments & Supplies Rankings?

BAX is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Baxter International Inc.’s Valuation?

What is Baxter International Inc.'s intrinsic value in 2026?

CirclFi puts Baxter International Inc. (BAX)'s intrinsic value at $22.95 — the median of 6 independent model estimates as of 2026-08-28, ranging from $4.49 to $36.03. The Quality of Company score is 6.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BAX overvalued or undervalued right now?

At $26.13, 2 of 6 active models suggest BAX may be undervalued, while 4 indicate potential overvaluation. The median of all 6 fair value estimates is $22.95, 12.2% below the current price of $26.13 — a consensus view that BAX is overvalued. The assessment depends on which methodology best fits Baxter International Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 6.3 mean for BAX?

Baxter International Inc.'s QOC of 6.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on BAX?

CirclFi analyzes BAX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on BAX?

Of the 6 models currently active on BAX, Regime Cross-Sectional is the most bullish at $36.03 per share, and Sentiment SOTP is the most bearish at $4.49. CirclFi's published fair value for BAX is the median of that range, $22.95, not either extreme. The gap between the two ends equals 137% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is BAX a value trap in 2026?

Baxter International Inc.'s Value Trap score is 48/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries.

Cite this analysis — “According to CirclFi’s 6-model valuation engine, Baxter International Inc. (BAX) has a median fair value of $22.95 — 12.2% below the current price of $26.13 — as of 2026-08-28.” Source: circlfi.com/stock/BAX/ · Methodology
Primary sources for this BAX valuation
  • Financial statements: Baxter International Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000010456) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BAX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on BAX.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for BAX Unlock All 6 — $39/mo